BELOVED MARTEY: Open Payments
NPI 1396337044 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,855 in 151 payments from 13 companies in 2025. Trend: 2023 $1,462 · 2024 $1,514 · 2025 $2,855
Food & beverage: $2,784Education: $71
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 31 | $646 |
| Alkermes, Inc. | 25 | $564 |
| Teva Pharmaceuticals USA, Inc. | 25 | $559 |
| ABBVIE INC. | 24 | $341 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $195 |
| Janssen Pharmaceuticals, Inc | 7 | $122 |
| Lundbeck LLC | 7 | $114 |
| Neurocrine BioSciences, Inc. | 6 | $110 |
| Supernus Pharmaceuticals, Inc. | 5 | $73 |
| Otsuka America Pharmaceutical, Inc. | 4 | $63 |
Products named: COBENFY, ARISTADA, VRAYLAR, UZEDY, CAPLYTA, AUSTEDO XR, LYBALVI, INVEGA SUSTENNA.
Industry payments across NJ — which companies pay providers there.
